And therein lies the risk: research labs may become wholly dependent on companies whose agendas are fundamentally commercial. In exchange for access to compute and frontier models, labs may cede control over data, methods, and IP—letting private firms quietly extract value from publicly funded research. What begins as partnership can end in capture.